Follow The Filings

BBOT

Health Care, filed as BRIDGEBIO ONCOLOGY THERAPEUT (COM NEW), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 2 Owners
  • Max 0.5%
  • $5.7M
  • 1 add

In 2026 Q2 James Silverman added to BBOT.

Who owns this now

Largest portfolio weights among holders, up to 0.5% (James Silverman, Opaleye Management). Not free-float ownership.

  1. James Silverman Add 0.48%
  2. David Witzke 0.05%

Who owns BBOT

Sorted by value, long equity only, as of 2026 Q2.

History
James Silverman, Opaleye Management 0.48%, was 0.06% Add +1213.8% 700,000 $5.3M History
David Witzke, Avidity Partners Management 0.05% Hold 43,853 $334K History

2 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by BBOT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BBOT insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales

No open-market buys or sales on file.

Also filed in the last 12 months, not counted as buying or selling: 13 share withholdings for taxes, 4 stock grants, and 4 other transactions.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
8-K 8.01,9.01 Filing Doc
424B3 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 5.02,5.07 Filing Doc
424B3 Filing Doc
424B3 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
424B3 Filing Doc
8-K 5.02 Filing Doc
424B3 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
424B3 Filing Doc

Source: SEC EDGAR submissions, updated 9 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2024 FY2025
Net income $7.6M -$134.04M

Balance sheet

Metric FY2024 FY2025
Total current assets $1.95M $432.4M
Total non-current assets * $192.47M $15.98M
Total assets $194.42M $448.38M
Total current liabilities $0.188M $35.04M
Total non-current liabilities * $5.52M $2.24M
Total equity -$3.73M $411.1M

Cash flow

Metric FY2024 FY2025
Cash from operations -$0.764M -$113.89M
Cash from investing -$184M $73.33M
Cash from financing $186.46M $383.4M
Net change in cash * $1.7M $342.84M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.